Medicine

3 articles

Scientist in a lab with a vial of Pfizer's berobenatide, symbolizing a breakthrough in obesity treatment with potential for monthly dosing.

Pfizer's obesity drug shows potential for monthly dosing

Mid-stage study data reveals Pfizer's experimental obesity drug, berobenatide, could achieve significant weight loss with a groundbreaking monthly dosing schedule, a stark contrast to current weekly o

Aram Sarkisian·June 7, 2026

Microscopic view of human cells in a lab dish exhibiting rhythmic oscillations, visualizing the segmentation clock's activity during early development.

Cosmos & Space

Scientists Map Human Segmentation Clock Oscillations In Vitro

In a laboratory setting, human cells derived from urine now rhythmically "tick" every five hours, recapitulating the fundamental biological process that orchestrates the formation of our spine and rib

Aram Sarkisian·May 26, 2026

FDA advisory panel in a hearing room, with a split decision on AstraZeneca's breast cancer drug, casting uncertainty for patients.

Health & Medicine

FDA advisory panel rejects AstraZeneca breast cancer drug

A U.S. Food and Drug Administration advisory committee voted 3 to 6 against the benefit-risk profile of AstraZeneca's breast cancer drug camizestrant, according to AstraZeneca . This decision creates

Aram Sarkisian·May 22, 2026